HOOKIPA Achieves $10 Million Milestone Payment in Development of Immunotherapy for KRAS-Mutated Cancers
February 13, 2023 07:00 ET
|
HOOKIPA Pharma Inc.
NEW YORK and VIENNA, Austria, Feb. 13, 2023 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapies based on its proprietary arenavirus...
HOOKIPA announces strategic collaboration and license agreement with Roche to develop novel arenaviral immunotherapy for KRAS-mutated cancers
October 20, 2022 07:00 ET
|
HOOKIPA Pharma Inc.
Roche to receive license for HOOKIPA’s HB-700 program and option to license a second undisclosed novel arenaviral immunotherapyHOOKIPA to receive $25 million in upfront cash as well as potential...
Synlogic Achieves Research Milestone in Collaboration with Roche for Development of Novel Synthetic Biotic to Treat Inflammatory Bowel Disease
September 06, 2022 07:00 ET
|
Synlogic, Inc.
CAMBRIDGE, Mass., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, announced today...
Abrupt global expansion of the monkey pox virus has increased the demand for Monkey pox Disease Diagnostics Market - By PMI
August 25, 2022 08:53 ET
|
PMI
Covina, Aug. 25, 2022 (GLOBE NEWSWIRE) -- The virus that causes smallpox and the monkeypox both belong to the same family of viruses. Two outbreaks of a disease resembling the pox in groups of...
Immunodiagnostics Market is estimated to be US$ 39.69 billion by 2030 with a CAGR of 7.50% during the forecast period - By PMI
May 04, 2022 09:32 ET
|
PMI
Covina, May 04, 2022 (GLOBE NEWSWIRE) -- Immunodiagnostics is a field of in vitro diagnostics that uses antigen antibody responses to diagnose disease. It is used to diagnose infectious infections...
Innit Expands Partnership With Roche Diabetes Care France for Healthy Eating, Enabling Connection to Blood Glucose Meters
April 20, 2022 08:00 ET
|
Innit, Inc
SAN FRANCISCO, April 20, 2022 (GLOBE NEWSWIRE) -- Innit, an innovator in the field of personalized food technology, today announced the extension of its strategic partnership with Roche Diabetes...
Innovaccer Announces Collaboration with Roche to Develop Clinical Decision Support and Workflow Solutions
September 29, 2021 10:33 ET
|
Innovaccer Inc.
SAN FRANCISCO, Sept. 29, 2021 (GLOBE NEWSWIRE) -- Today Innovaccer Inc., the Health Cloud company, announced it has entered into a three-year collaboration with Roche to partner in the development...
AnPac Bio and Roche Pharmaceuticals China Entered into Cooperation to Explore Innovative Healthcare and Medical Solutions
August 05, 2021 07:30 ET
|
Anpac Bio, USA
PHILADELPHIA, Aug. 05, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
GENMARK ALERT: Bragar Eagel & Squire, P.C. Investigates Recently Announced Tender Offer for GNMK and Encourages Investors to Contact the Firm
March 31, 2021 19:50 ET
|
Bragar Eagel & Squire
NEW YORK, March 31, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, advises that a tender offer to acquire GenMark Diagnostics, Inc....
GENMARK ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of GNMK and Encourages Investors to Contact the Firm
March 15, 2021 13:57 ET
|
Bragar Eagel & Squire
NEW YORK, March 15, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of...